Trial intelligence / Profile preview

Low-dose mirtazapine and quetiapine effects on sleep and daytime functioning

2013-003460-31Phase 4Active

Sponsor
GGZ Drenthe
Start
Dec 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of mirtazapine and quetiapine in Insomnia (2 arms), sponsored by GGZ Drenthe. Primary endpoints: Polysomnographically measured sleep and Subjective sleep measures. Started Dec 2013; status: active.

02

Drugs

mirtazapinequetiapine
03

Conditions

Insomnia

Beyond the preview

Go deeper on 2013-003460-31.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2013-003460-31.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call